Share This

Hot News

【新股IPO】沛嘉醫療集資最多23.4億入場費15515元- 香港經濟日報- 即時新聞頻道- 金融經濟 @ 2020-05-06T16: Back Hot News
Keyword:孖展 首日 沛嘉醫療 超購 經濟
Concept:沛嘉首日孖展 , 沛嘉醫療首日招股超購
沛嘉的入場費偏高,散戶昨現借錢抽新股熱潮。本報統計6家券商數據,包括輝立、耀才、信誠、第一上海、時富及富途,昨日共計借出529.99億元孖展(見表),相當於公開發售超購225倍。與近月較出色的B股比較,康方生物當時首日錄276億元孖展,諾誠健華(9969)則借出368億元,沛嘉已超越二者紀錄。
另外,昨首日招股的建業新生活 (新上市編號:09983),孖展認購金額錄48.9億,超購21.6倍,當中15億元來自輝立證券、13.93億元來自富途、11億元來自信誠。
沛嘉醫療 (新上市編號:09996)首日招股,券商首日已錄強勁孖展認購,當中輝立孖展達200億元、耀才孖展達150億元、信誠孖展達105億元,首日整體市場的孖展額約599億元,相當於超額認購約254倍。
相關文章:【新股IPO】沛嘉醫療首日孖展錄599億 超購254倍
內地綜合IT解決方案及雲服務提供商伊登軟件 (新上市編號:01147)於今日招股,綜合多間券商數據顯示,公司首日孖展錄得5468萬元孖展認購,超購3.37倍。另外,新加坡室內裝修服務供應商RAFFLES INTERIOR (新上市編號:01376) 錄得8877萬元孖展認購,超購4.46倍。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.